Background Many patients with papillary thyroid cancer (PTC) demonstrate satisfactory
outcomes. However, 8%–28% of patients with PTC show tumor recurrence, which may affect …

Objective Evidence for unfavorable outcomes of each type of aggressive variant papillary
thyroid carcinoma (AV-PTC) is not clear because most previous studies are focused on tall …

The term poorly differentiated thyroid carcinoma (PDTC) was first proposed in the 1980s, but
it was not definitively recognized as a distinct pathologic entity until the most recent …

Purpose: To evaluate the role of radioiodine and external radiotherapy treatment in papillary
thyroid carcinoma (PTC). Methods and Materials: This is a retrospective study of 842 …

Materials and Methods: A total of 1858 patients with PTC operated on by the same surgeon,
and followed in the same center over a period of 35 years, were included. Total …

AIM: The aim of the study was to study the percentage distribution of PTC among total
thyroid specimens, the age and sex distribution of PTC, its histopathological features …

Abstract Background In 2002, the UICC/AJCC TNM classification for papillary thyroid
carcinoma was revised. In this study, we examined the validity of this classification system by …

Background To evaluate the results of treatment and the prognostic variables of papillary
thyroid carcinoma patients after long‐term follow‐up. Patients and Methods Retrospective …

Background: The occurrence of recurrent papillary and follicular thyroid carcinomas is not
unusual. Numerous studies have reported the association between risk factors of initial …

OBJECTIVE Although in most cases differentiated thyroid carcinoma (DTC) responds to
surgery and radioiodine (RaI) therapy, some patients will have recurrence and eventually …